TrialReach: a new way to match patients with clinical trials

TrialReach is an interesting new service for matching clinical trials with patientsto develop their service for matching patients with available clinical trials. This is a really cool idea. One of the things holding back research into rare diseases like SJIA is getting enough participants into the clinical trials so that the research can happen.

Searching on the site immediately turned up one clinical trial mentioning Systemic JIA, but unfortunately it was mentioning it as an *exclusion*. The trial is for a drug called Tofaxinab, which is sponsored by Pfizer. So there’s no new SJIA drug trials on the site that we didn’t already know about, but we’ll keep an eye out for new clinical trials as they are listed.